BIOMARIN PHARMACEUTICAL INC Public Float
BIOMARIN PHARMACEUTICAL INC (BMRN) had Public Float of $6.70 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $6.70B.
- 2024-06-28: Entity Public Float $8.70B.
- 2023-06-30: Entity Public Float $10.10B.
- 2022-06-30: Entity Public Float $9.00B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.70B 10-K · filed 2026-02-26 |
| 2024-06-28 | $8.70B 10-K · filed 2025-02-24 |
| 2023-06-30 | $10.10B 10-K · filed 2024-02-26 |
| 2022-06-30 | $9.00B 10-K · filed 2023-02-27 |
| 2021-06-30 | $8.40B 10-K · filed 2022-02-25 |
| 2020-06-30 | $13.90B 10-K · filed 2021-02-26 |
| 2019-06-30 | $8.10B 10-K · filed 2020-02-27 |
| 2018-06-30 | $8.80B 10-K · filed 2019-02-28 |
| 2017-06-30 | $8.50B 10-K · filed 2018-02-26 |
| 2016-06-30 | $7.60B 10-K · filed 2017-02-27 |
| 2015-06-30 | $15.20B 10-K · filed 2016-02-29 |
| 2014-06-30 | $5.50B 10-K · filed 2015-03-02 |
| 2013-06-30 | $5.08B 10-K · filed 2014-02-26 |
| 2012-06-30 | $2.74B 10-K · filed 2013-02-26 |
| 2011-06-30 | $2.03B 10-K · filed 2012-02-22 |
| 2010-06-30 | $1.03B 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |